4. CNS/Mental Health Flashcards
(50 cards)
Alprazolam
Pharmacologic Category
- Xanax™
- Xanax XR™
- Niravam™
- Gabazolamine-0.5™
- Antianxiety
- Benzodiazepine
Alprazolam
FDA Approved Indications/Uses
- Xanax™
- Xanax XR™
- Niravam™
- Gabazolamine-0.5™
- Anxiety
- Panic disorder
Alprazolam
Adverse Effects
- Xanax™
- Xanax XR™
- Niravam™
- Gabazolamine-0.5™
- Decreased appetite
- Increased appetite
- Weight gain
- Constipation
- Reduced salivation
- Xerostomia
- Cognitive disorder
- Confusion
- Dysarthria
- Incoordination
- Lightheadedness
- Memory impairment
- Sedation
- Somnolence
- Irritability
- Reduced libido
- Fatigue
- Stevens-Johnson Syndrome
- Liver failure
- Drug withdrawal seizure
Alprazolam
Dosage Forms
- Xanax™
- Xanax XR™
- Niravam™
- Gabazolamine-0.5™
- Tablet
- Tablet, disintegrating
- Tablet, ER
Alprazolam
Patient Education
- Xanax™
- Xanax XR™
- Niravam™
- Gabazolamine-0.5™
- Patient should avoid activities requiring mental alertness or coordination until drug effects are realized.
- This drug may cause increased appetite, changes in weight, constipation, dizziness, dysarthria, memory impairment, somnolence, depression, or reduced libido.
- Advise patient and family to monitor for confusion with use, especially with elderly patients.
- Advise patient against abrupt discontinuation of drug to prevent withdrawal symptoms.
- Patient should avoid alcohol while taking drug.
- Patient should not eat grapefruit or drink grapefruit juice while taking drug.
Amitriptyline
Pharmacologic Category
- Elavil™
- Vanatrip™
- Tricyclic antidepressant
Amitriptyline
FDA Approved Indications/Uses
- Elavil™
- Vanatrip™
- Depression
Amitriptyline
Adverse Effects
- Elavil™
- Vanatrip™
- Weight gain
- Constipation
- Xerostomia
- Dizziness
- Headache
- Somnolence
- Blurred vision
Amitriptyline
Dosage Forms
- Elavil™
- Vanatrip™
- Tablet
Amitriptyline
Patient Education
- Elavil™
- Vanatrip™
- Instruct patient to report use of a MAO inhibitor within 14 days prior to initiating drug therapy.
- Patient should avoid activities requiring mental alertness or coordination until drug effects are realized.
- This drug may cause anticholinergic symptoms, weight gain, bloating, fatigue, orthostatic hypotension, or syncope.
- Instruct patient to report worsening depression, suicidal ideation, or unusual changes in behavior, especially at initiation of therapy or with dose changes. Children and adolescents are at higher risk for these effects during the first few months of therapy.
- Advise patient that symptomatic improvement may not be seen for a few weeks.
- Warn patient against sudden discontinuation of drug.
- Patient should not drink alcohol while taking this drug.
Bupropion
Pharmacologic Category
- Wellbutrin
- Zyban
- Wellbutrin SR
- Wellbutrin XL
- Budeprion SR
- Buproban
- Budeprion XL
- Forfivo XL
- Aminoketone
- Antidepressant
Bupropion
FDA Approved Indications/Uses
- Wellbutrin
- Zyban
- Wellbutrin SR
- Wellbutrin XL
- Budeprion SR
- Buproban
- Budeprion XL
- Forfivo XL
- Depression
- Associated with seasonal affective disorder
- Prophylaxis
- Major depressive disorder
- Smoking cessation assistance
Bupropion
Adverse Effects
- Wellbutrin
- Zyban
- Wellbutrin SR
- Wellbutrin XL
- Budeprion SR
- Buproban
- Budeprion XL
- Forfivo XL
- Tachyarrhythmia
- Constipation
- Nausea
- Rash, pruritis
- Myalgia
- Confusion, dizziness, headache,
- Insomnia
- Tremor
- Xerostomia (Dry mouth)
Bupropion
Dosage Forms
- Wellbutrin
- Zyban
- Wellbutrin SR
- Wellbutrin XL
- Budeprion SR
- Buproban
- Budeprion XL
- Forfivo XL
- Tablet
- Tablet, XR
- Tablet, IR
- Tablet, SR
Bupropion
Patient Education
- Wellbutrin
- Zyban
- Wellbutrin SR
- Wellbutrin XL
- Budeprion SR
- Buproban
- Budeprion XL
- Forfivo XL
- Do not drink alcohol while you are using this medicine.
- Take extended-release tablets in the morning to avoid insomnia
- Do not crush or chew tablets
- Do not take OTC meds before consulting to your doctor
- May increase suicidal thoughts or actions
- Continued treatment up to 2 weeks is needed to see results
- Weight loss or gain may happen
Citalopram
Pharmacologic Category
Celexa™
- SSRI
- Antidepressant
Citalopram
FDA Approved Indications/Uses
Celexa™
- Depression
Citalopram
Adverse Effects
Celexa™
- Diaphoresis (sweating)
- Constipation
- Diarrhea
- Vomiting
- Xerostomia (dry mouth)
- Hip fracture (46%)
- Dizziness, headache
- Insomnia
- Sedated, somnolence (excess sleepiness)
- Tremor
- Disorder of ejaculation
- Fatigue
Citalopram
Dosage Forms
Celexa™
- Tablet
- Solution
Citalopram
Patient Education
Celexa™
- May impair cognitive and motor performance
- Take this medicine as directed. You may need to take it for a month or more before you feel better. Your dose may need to be changed to find out what works best for you.
- Do not take this medicine and an MAO inhibitor (MAOI) within 14 days of each other.
- This medicine can increase thoughts of suicide.
- Don’t get pregnant.
- Don’t drink alcohol.
Duloxetine
Pharmacologic Category
- Cymbalta™
- Irenka™
- Drizalma Sprinkle™
- SSNRI
- Antidepressant
- Antianxiety
Duloxetine
FDA Approved Indications/Uses
- Cymbalta™
- Irenka™
- Drizalma Sprinkle™
- Major depressive disorder (MDD)
- Diabetic peripheral neuropathy - Pain
- Fibromyalgia
- Generalized anxiety disorder (GAD)
- Musculoskeletal pain, Chronic
Duloxetine
Adverse Effects
- Cymbalta™
- Irenka™
- Drizalma Sprinkle™
- Diaphoresis (sweating)
- Constipation
- Decrease in appetite
- Diarrhea
- Nausea
- Xerostomia (dry mouth)
- Dizziness, headache
- Insomnia
- Somnolence (excess sleepiness)
- Erectile dysfunction (in card)
Duloxetine
Dosage Forms
- Cymbalta™
- Irenka™
- Drizalma Sprinkle™
- Capsule, DR
- Paste